
The federal agency recommends using either PCV13 or PCV15 as part of a 4-dose series for pediatric patients between the ages of 2-59 months.
Yosef Nissim, PharmD, BCIDP, is an infectious diseases clinical pharmacist at Ocean University Medical Center in Brick, NJ. After graduating from the Philadelphia College of Pharmacy in 2018, he completed his PGY1 and PGY2 infectious diseases residency at WVU Hospitals in Morgantown, WV.